Orthopedic SurgeryUNITENCT05257278
MonoPlus® in Orthopedic Surgery
An observational study of Orthopedic Surgery and Soft Tissue Approximation, run by Aesculap AG at 1 site in Spain.
Trial summary
Single-center postmarket clinical follow-up study (PMCF) on the performance and safety of MonoPlus® in patients undergoing orthopedic surgery Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Orthopedic Surgery, Soft Tissue Approximation
- What is being tested?
- MonoPlus®
- Type of treatment
- Medical device
- How many people
- 140 participants
- Where
- 1 siteSpain
- Study dates
- 18 Jan 2022to 7 Jul 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All male of femal patients are eligible for inclusion in this study when they are in need of orthopedic surgery and MonoPlus® is used for soft tissue approximation for this orthopedic surgery in the routine clinical practice
Who may be able to join
- Male or female patients
- Need for orthopedic surgery
- Use of MonoPlus® for the orthopedic surgery in the routine clinical practice
- Written informed consent form.
Who cannot join
- Any medical or psychological disorder that, in the investigator's opinion, may interfere with the patient's ability to give informed consent and comply with the study procedures
- Prosthetic surgery secondary to infection
- Radiation to the surgical area
- Participation or planned participation in any clinical trial before study follow-up is completed
- Previous tendon/ligament repair intervention
- Pregnancy
- Patients with hypersensitivity or allergy to the suture material
- Patients taking medical consumption that might affect wound healing.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Single-center PMCF - Study on the Performance and Safety of MonoPlus® in Patients Undergoing Orthopedic Surgery
Single-center postmarket clinical follow-up study (PMCF) on the performance and safety of MonoPlus® in patients undergoing orthopedic surgery
Read the detailed description
This post-market clinical follow-up (PMCF) study on the use of MonoPlus®, a polydioxanone absorbable suture material, will expand the information available on the performance and safety of MonoPlus® used for orthopedic surgeries conducted in daily practice conditions.
The study is designed as a prospective, non-interventional, single-center, PMCF cohort study. The product under investigation will be used in routine clinical practice and according to the Instructions for Use. No diagnostic or therapeutic intervention outside of routine clinical practice will be applied, and all study visits will coincide with those that will be scheduled for routine follow-up.
- Conditions
- Orthopedic Surgery, Soft Tissue Approximation
- Being tested
- MonoPlus®
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MonoPlus®Device
MonoPlus® is indicated for use in general soft tissue approximation, specially in cases where extended wound support of more than 4 weeks is desirable
| Study group | Role | What they receive |
|---|---|---|
| MonoPlus® | Patients undergoing orthopedic surgery with soft tissue approximation Receives: Device: MonoPlus® |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of maintained soft tissue approximation
For the assessment of MonoPlus® effectiveness the percentage of patients that maintain soft tissue approximation integrity examined by ultrasound is evaluated
Measured: 3 months post-surgery
Secondary outcomes (11)
Changes in functional performance for Patients undergoing Knee surgery
Mean changes in functional performance from baseline to week 6 and month 3 after surgery according to the Oxford Knee Score (OKS). OKS is a short 12-item patient-reported outcome(PRO) specifically designed and developed to assess function and pain with patients undergoing knee replacement surgery. When the OKS was originally developed, it was designed to be as simple as possible for ease of use. The scoring system is a 0-5 where one represented the best outcome. Item scores are summed to give a total score. The lower the score, the better the outcome.
Measured: preoperatively, 6 weeks and 3 months post-surgery
Changes in functional performance for Patients undergoing Hip surgery
Mean changes in functional performance from baseline to week 6 and month 3 after surgery according to the Oxford Hip Score (OHS). The Oxford Hip Score (OHS) is a short 12-item patient-reported patient-reported outcome (PRO) specifically designed and developed to assess function and pain with patients undergoing hip replacement surgery. The OKS is a patient reported outcome measure that consists of 12 questions about an individual's level of function, activities of daily living and how they have been affected by pain over the preceding four weeks. Each item has five possible responses from 0 to 5. Item scores are summed to give a total score. The lower the score, the better the outcome.
Measured: preoperatively, 6 weeks and 3 months post-surgery
Changes in functional performance for Patients undergoing upper extremity surgery
Mean changes in functional performance from baseline to week 6 and month 3 after surgery according to the Quick Disability of Arm, Shoulder and Hand score (QuickDASH). The QuickDASH,is a subset of 11 items from the 30-item Disability of Arm, Shoulder and Hand score and is a self-reported questionnaire. The response options are presented as 5-point Likert scales. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability). This score was designed be useful in patients with any musculoskeletal disorder of the upper limb.
Measured: preoperatively, 6 weeks and 3 months post-surgery
Changes in strength
Mean changes in strength measured by a dynamometer from baseline to week 6 and month 3 after surgery.
Measured: at baseline, 6 weeks and 3 months post-surgery.
Incidence of reoperations
Frequency of reoperation within the 12 months after surgery.
Measured: Up to last follow up 12 months post operatively
The length of hospital stay after the orthopedic surgery.
Mean duration of hospital stay in patients undergoing orthopedic surgery.
Measured: up to hospital discharge (approximately 10 days postoperatively)
The incidence of post-surgery complicated wound healing.
Frequency of patients with complicated wound healing within the first 6 weeks post-surgery. A complicated wound healing will be recorded if the incision does not close completely, necrosis of the wound edge or primary or secondary dehiscence occur, or in cases of formation of a seroma, fistula, or bleeding.
Measured: 12-month study follow-up.
The incidence of wound infections during the study follow-up.
Frequency of wound infections within the 12-month post-surgery follow-up. Wound infection is defined as redness, wound dehiscence with secretion (putrid or caliginous fluid), and / or microbiological evidence of bacterial contamination.
Measured: 12-month study follow-up.
Development of Pain measured with Visual Analogue Scale (VAS)
Mean pain VAS scores at rest and with activity at five different points of time (baseline, hospital discharge, 6 weeks, 3 months and 12 months after surgery. Visual Analogue Scale is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. The most simple VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom,pain,health) orientated from the left (worst) to the right (best).
Measured: Preoperatively, hospital discharge (approximately 10 days postoperatively), 6 weeks, 3 months and 12 months after surgery
Rate of Adverse Device Effects
Frequencies of patients with Adverse Device Effects (ADE) reported until month 12 after surgery.
Measured: up to last follow-up at 12 months postoperatively
Assessment of intraoperative handling of suture material
Assessment of intraoperative handling of suture material using a questionnaire (Likert Scale) including various dimensions (knot security, tensile strength, knot run down, tissue drag and pliability) with 5 evaluation levels ('excellent' (5), 'very good' (4), 'good' (3), 'satisfied' (2) and 'poor' (1)).
Measured: intraoperatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Feb 2022
- Study start18 Jan 2022
- Primary completion7 Jul 2023
- Study completion7 Jul 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Orthopedic SurgeryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 140 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aesculap AG
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- B.Braun Surgical SA
- Responsible party
- Sponsor
- Investigators
- Pablo Sanz Ruiz, Principal investigator, Gregorio Marañón Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05257278
- Sponsor's protocol ID
- AAG-O-H-2027
- Acronym
- UNITE
- Status last verified
- Sep 2024
- First submitted
- 17 Feb 2022
- Last updated
- 19 Sep 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Single-center PMCF - Study on the Performance and Safety of MonoPlus® in Patients Undergoing Orthopedic Surgery
- ClinicalTrials.gov ID
- NCT05257278
- Acronym / sponsor ID
- UNITE / AAG-O-H-2027
- Conditions
- Orthopedic Surgery, Soft Tissue Approximation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 140 participants (actual)
- Lead sponsor
- Aesculap AGIndustry (pharma, biotech, devices)
- Collaborators
- B.Braun Surgical SA
- Study start
- 18 Jan 2022 (actual)
- Primary completion
- 7 Jul 2023 (actual)
- Study completion
- 7 Jul 2024 (actual)
- First posted
- 25 Feb 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Single-center postmarket clinical follow-up study (PMCF) on the performance and safety of MonoPlus® in patients undergoing orthopedic surgery
Detailed description
This post-market clinical follow-up (PMCF) study on the use of MonoPlus®, a polydioxanone absorbable suture material, will expand the information available on the performance and safety of MonoPlus® used for orthopedic surgeries conducted in daily practice conditions.
The study is designed as a prospective, non-interventional, single-center, PMCF cohort study. The product under investigation will be used in routine clinical practice and according to the Instructions for Use. No diagnostic or therapeutic intervention outside of routine clinical practice will be applied, and all study visits will coincide with those that will be scheduled for routine follow-up.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| MonoPlus® | – | Device: MonoPlus®Patients undergoing orthopedic surgery with soft tissue approximation |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All male of femal patients are eligible for inclusion in this study when they are in need of orthopedic surgery and MonoPlus® is used for soft tissue approximation for this orthopedic surgery in the routine clinical practice
Key inclusion criteria (4 listed)
- Male or female patients
- Need for orthopedic surgery
- Use of MonoPlus® for the orthopedic surgery in the routine clinical practice
- Written informed consent form.
Key exclusion criteria (8 listed)
- Any medical or psychological disorder that, in the investigator's opinion, may interfere with the patient's ability to give informed consent and comply with the study procedures
- Prosthetic surgery secondary to infection
- Radiation to the surgical area
- Participation or planned participation in any clinical trial before study follow-up is completed
- Previous tendon/ligament repair intervention
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MonoPlus®MonoPlus® is indicated for use in general soft tissue approximation, specially in cases where extended wound support of more than 4 weeks is desirable | Device | MonoPlus® |
Primary outcome
Rate of maintained soft tissue approximation
Time frame: 3 months post-surgery
For the assessment of MonoPlus® effectiveness the percentage of patients that maintain soft tissue approximation integrity examined by ultrasound is evaluated
11 secondary outcomes
Changes in functional performance for Patients undergoing Knee surgery
Time frame: preoperatively, 6 weeks and 3 months post-surgery
Changes in functional performance for Patients undergoing Hip surgery
Time frame: preoperatively, 6 weeks and 3 months post-surgery
Changes in functional performance for Patients undergoing upper extremity surgery
Time frame: preoperatively, 6 weeks and 3 months post-surgery
Changes in strength
Time frame: at baseline, 6 weeks and 3 months post-surgery.
Incidence of reoperations
Time frame: Up to last follow up 12 months post operatively
The length of hospital stay after the orthopedic surgery.
Time frame: up to hospital discharge (approximately 10 days postoperatively)
The incidence of post-surgery complicated wound healing.
Time frame: 12-month study follow-up.
The incidence of wound infections during the study follow-up.
Time frame: 12-month study follow-up.
Development of Pain measured with Visual Analogue Scale (VAS)
Time frame: Preoperatively, hospital discharge (approximately 10 days postoperatively), 6 weeks, 3 months and 12 months after surgery
Rate of Adverse Device Effects
Time frame: up to last follow-up at 12 months postoperatively
Assessment of intraoperative handling of suture material
Time frame: intraoperatively
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
Related trials for Orthopedic Surgery
Enrolling by invitationPhase 4
PPP Versus Corticosteroid for Thigh Muscle Injuries
Thigh Muscle Injury, Thigh Injury
Not yet recruiting
Comparison of Telerehabilitation and Usual Rehabilitation After Knee or Hip Surgery
Orthopedic Surgery, Rehabilitation
Active, not recruitingPhase 2
Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
Orthopedics, Traumatology
Recruiting
Intermittent Fasting Versus Carbohydrate Drinks Before Surgery
Perioperative Care, Intermittent Fasting
Not yet recruitingPhase 4
Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture
Hip Fractures (ICD-10 72.01-72.2), Post Operative Analgesia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pablo Sanz Ruiz principal investigator
Gregorio Marañón Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Orthopedic Surgery and Soft Tissue Approximation, run by Aesculap AG at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of maintained soft tissue approximation (time frame: 3 months post-surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.